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A B S T R A C T
Glycine tissue concentrations are increased particularly in nonketotic and ketotic hyperglycinemia,
inherited metabolic disorders characterized by severe neurologic damage and brain abnormalities. The
present work investigated the in vitro effects of glycine on important parameters of energy metabolism
in the brain of young rats. The parameters analyzedwere CO2 generated from glucose, acetate and citrate
and the activities of the respiratory chain complexes I–IV, of the citric acid cycle enzymes citrate
synthase, aconitase, isocitrate dehydrogenase,a-ketoglutarate dehydrogenase, succinate dehydrogense,
fumarase and malate dehydrogenase, of creatine kinase and Na+,K+-ATPase. Our results show that
glycine signiﬁcantly reduced CO2 production from acetate, but not from glucose and citrate, reﬂecting an
impairment of the citric acid cycle function. We also observed that the activity of the mitochondrial
enzyme citrate synthase wasmarkedly inhibited by glycine, whereas the other activities of the citric acid
cycle were not altered. Furthermore, the activity of the respiratory chain was reduced at complexes I–III,
II–III and II, as well as of the mitochondrial isoform of creatine kinase and Na+,K+-ATPase. The data
indicate that glycine severely impairs brain bioenergetics at the level of energy formation, transfer and
utilization. Considering the importance of energy metabolism for brain development and functioning, it
is presumed that glycine-induced impairment of brain energy homeostasis may be involved at least in
part in the neurological damage found in patients affected by disorders in which brain glycine
concentrations are increased.
 2010 Elsevier Ltd.
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Open access under the Elsevier OA license. 1. Introduction
Nonketotic hyperglycinemia (NKH) is an autosomal recessive
disorder of glycine (Gly)metabolism caused by deﬁcient activity of
the glycine cleavage system (GCS) (E.C. 2.1.1.10). Although GCS
encompasses 4 different proteins, P-protein (a pyridoxal phos-
phate-containing protein), T-protein (tetrahydrofolate-requiring
amino methyltransferase), L-protein (lipoamide dehydrogenase)
andH-protein (lipoic acid containing protein) (Kikuchi et al., 2008),
NKH is usually associated to the deﬁciency of P-protein and, to a
less frequently, of T-protein (Hamosh and Johnston, 2001). NKH is
biochemically characterized by the accumulation of Gly in cerebral
spinal ﬂuid (CSF), blood and urine of affected patients, with a
signiﬁcantly characteristic elevation of the CSF/plasma Gly ratio* Corresponding author at: Departamento de Bioquı´mica, Universidade Federal
do Rio Grande do Sul, Rua Ramiro Barcelos, 2600 - Anexo, CEP 90035-003, Porto
Alegre, RS, Brazil. Tel.: +55 5133085571; fax: +55 5133085540.
E-mail address: mwajner@ufrgs.br (M. Wajner).
0197-0186  2010 Elsevier Ltd.
doi:10.1016/j.neuint.2010.04.002
Open access under the Elsevier OA license. (normal < 0.04). A ratio > 0.08 is usually considered diagnostic of
classical NKH and should be followed by the analysis of GCS
activity in liver tissue. The overall NKH prevalence is estimated in
1:60,000 newborns (Applegarth et al., 2000), although higher
frequencies were reported in northern Finland, British Columbia
and in small Arab villages in Israel (von Wendt et al., 1980; Boneh
et al., 2005). Clinically, most patients have the classical formwhich
appears in the neonatal period with lethargy, coma, seizures and
apnea, as well as congenital brain malformations such as agenesis
or hypoplasia of the corpus callosum, and the combination of a
retrocerebellar cyst with hydrocephalus (Dobyns, 1989; Van Hove
et al., 2000). Patients with late-onset variant forms exhibit a
variable degree of mental retardation and seizures (Hamosh and
Johnston, 2001; Steiner et al., 1996). Furthermore, a few patients
have been described with the features of neonatal NKH, but the
biochemical and clinical symptoms disappeared in infancy. The
outcome of these patients has been variable (Aliefendiog˘lu et al.,
2003) and the etiology of this form is still unknown at present (Van
Hove et al., 2005). Early treatment consisting of sodium benzoate
and dextromethorphan administration improves the neurological
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(Korman et al., 2006).
Although the pathogenesis of the brain lesions found in NKH is
still unknown, it is well recognized that situations with catabolic
stress lead to increase of blood Gly tissue concentrations and
worsening of patients’ symptomatology and that oral Gly load
causes electro-encephalographic changes (Frazier et al., 1978). In
addition, it has been reported a correlation between the increase of
CSF/plasma Gly ratio and the severity of the disease (Hamosh and
Johnston, 2001). Taken together these observations, it is conceiv-
able that high Gly concentrations are toxic to the brain and are
possibly involved in the pathophysiology of brain damage in NKH
patients. On the other hand, it is well documented that Gly
stimulates NMDA receptors located in the hippocampus, cerebral
cortex, olfactory bulb, and cerebellum leading to excitotoxicity
(Patel et al., 1990; McNamara and Dingledine, 1990; Hara et al.,
1993; Kure et al., 1997; Kono et al., 2007; Katsuki et al., 2007). In
contrast, Gly also acts as an inhibitory neurotransmitter in the
brain stem, which can explain apnea, hiccups and hypotonia.
However, the underlying mechanisms of brain damage in this
disorder are far from being understood. It should be also stressed
that increased tissue amounts of Gly are also characteristic of
methylmalonic acidemia and propionic acidemia, two inherited
metabolic disorders with severe neurological dysfunction and
brain cortical atrophy.
Recently, it was demonstrated that Gly induces oxidative stress
in cerebral cortex of young rats in vitro, eliciting lipid and protein
oxidative damage and reducing the antioxidant defenses (Leipnitz
et al., 2008). However, to our knowledge the effect of Gly on brain
energy metabolism remains to be elucidated. Therefore, in the
present work we investigated the in vitro inﬂuence of Gly on
important parameters of cellular energy metabolism, namely CO2
production from [U-14C] glucose (aerobic glycolysis), [1-14C]
acetate or [1,5-14C] citrate, the enzyme activities of citric acid
cycle enzymes, respiratory chain complexes I–IV (respiratory chain
function), creatine kinase (cellular energy transfer) and Na+,K+-
ATPase activities in brain preparations from young rats.
2. Experimental procedures
2.1. Reagents
All chemicals were purchased from Sigma Chemical Co., St. Louis, MO, USA,
except for [U-14C] glucose, [1-14C] acetate and [1,5-14C] citrate, which were
purchased from Amersham International plc, UK.
2.2. Animals
Thirty-day-oldWistar ratsweighting 80–100 g obtained from the Central Animal
House of the Department of Biochemistry, ICBS, UFRGS, were used in the assays. The
animals had free access to water and to a standard commercial chow and were
maintained on a 12:12 h light/dark cycle in an air-conditioned constant
temperature (22  1 8C) colony room. The ‘‘Principles of Laboratory Animal Care’’
(NIH publication no. 80-23, revised 1996) were followed in all experiments and the
experimental protocol was approved by the Ethics Committee for Animal Research of
the Federal University of Rio Grande do Sul, Porto Alegre, Brazil. All efforts were made
to minimize the number of animals used and their suffering.
2.3. Cerebral preparations
The animals were sacriﬁced by decapitation, the brain was rapidly removed and
the cerebral cortex was isolated. For CO2 production, the cerebral cortex was
homogenized (1:10, w/v) in Krebs–Ringer bicarbonate buffer, pH 7.4 (KH2PO4
0.016%, NaCl 0.69%, KCl 0.035%, MgSO4 0.29%, CaCl2 0.037% and NaHCO3 5.46%). For
the determination of the activities of the respiratory chain complexes I–III, II, II–III
and IV, cerebral cortex was homogenized (1:20, w/v) in SETH buffer, pH 7.4
(250 mM sucrose, 2.0 mM EDTA, 10 mM Trizma base and 50 IU mL1 heparin). The
homogenates were centrifuged at 800  g for 10 min and the supernatants were
kept at 70 8C until being used for enzyme activity determination. For the
determination of the activities of citric acid cycle enzymes, mitochondrial enriched
fractions fromwhole brain were prepared according to Rosenthal et al. (1987), with
slight modiﬁcations. For total creatine kinase activity determination, the cerebral
cortex was homogenized (1:10, w/v) in isosmotic saline solution. For thepreparation of mitochondrial and cytosolic fractions, the homogenates were
centrifuged at 800  g for 10 min at 4 8C and the pellet discarded (Ramirez and
Jimenez, 2000). The supernatant was then centrifuged at 27,000  g for 30 min at
4 8C in a Sorval DC-2B centrifuge. The pellet containing the mitochondria was
washed three times with saline solution and used as the mitochondrial fraction for
the mitochondrial creatine kinase (mCK) enzymatic assay. The supernatants were
further centrifuged at 125,000  g for 60 min at 4 8C in an OTD-65B Sorval
centrifuge, themicrosomal pellet discarded, and the cytosol (supernatant) was used
for the determination of cytosolic creatine kinase activity. The period between
tissue preparation and measurement of the various parameters was always less
than 5 days, except for mitochondrial and cytosolic creatine kinase (cCK), citric acid
cycle enzymatic and CO2 production assays, which were performed in the same day
of the preparations.
The biochemical parameters were determined in the presence of various
concentrations of Gly (0.1, 0.5, 1.0 and 5.0 mM), whereas control groups did not
contain the amino acid in the incubation medium. Gly was dissolved on the day of
the experiments in the buffer used for each technique with pH adjusted to 7.4. We
always carried out parallel experiments with blanks (controls) in the presence or
absence of Gly and also with or without brain preparations in the reaction medium
in order to detect any interference (artifacts) of this amino acid on the techniques
utilized to measure the various biochemical parameters. The effects of alanine on
some biochemical parameters were also tested.
2.4. Preparation of synaptic plasma membrane from rat whole brain
Tissue was homogenized in 10 volumes of 0.32 mM sucrose solution containing
5.0 mMHEPES and 1.0 mM EDTA. Membranes were prepared afterwards according
to the method of Jones and Matus (1974) using a discontinuous sucrose density
gradient consisting of successive layers of 0.3, 0.8 and 1.0 mM. After centrifugation
at 69,000  g for 2 h, the fraction at the 0.8–1.0 mM sucrose interface was taken as
the membrane enzyme preparation. In some experiments, Gly (0.1–5.0 mM) or
alanine (5 mM) was incubated at 37 8C for 30 min with puriﬁed synaptic
membranes.
2.5. CO2 production
Homogenates prepared in Krebs–Ringer bicarbonate buffer, pH 7.4, were added
to small ﬂasks (11 cm3) in a volume of 0.45 mL. Flasks were pre-incubated at 35 8C
for 30 min in the presence of Gly (0.1–5.0 mM) in a metabolic shaker
(90 oscillations min1) with 625 mM n-dodecyl-b-D-maltoside in order to permea-
bilize themitochondrial membranes. Controls did not contain the metabolite in the
incubation medium. After pre-incubation, [U-14C] glucose (0.055 mCi) plus 5.0 mM
of unlabeled glucose, 0.055 mCi [1-14C] acetate plus 1.0 mM of unlabeled acetate or
0.055mCi [1,5-14C] citrate plus 1.0 mM of unlabeled citrate were added to the
incubation medium. In some experiments, the incubation medium also contained
1.0 mM coenzyme A. The ﬂasks were gassed with an O2/CO2 (95:5) mixture and
sealed with rubber stoppers Paraﬁlm M. Glass center wells containing a folded
60 nm/4 nm piece of Whatman 3 ﬁlter paper were hung from the stoppers. After
60 min incubation at 35 8C in a metabolic shaker (90 oscillations min1), 0.2 mL of
50% trichloroacetic acid was supplemented to the medium and 0.1 mL of
benzethonium hydroxide was added to the center of the wells with needles
introduced through the rubber stopper. The ﬂasks were left to stand for 30 min to
complete CO2 trapping and then opened. The ﬁlter paper were removed and added
to vials containing scintillation ﬂuid, and radioactivity was counted (Reis de Assis
et al., 2004). Results were calculated as rmol CO2 h
1 g tissue 1.
2.6. Spectrophotometric analysis of the respiratory chain complexes I–IV activities
The activities of succinate–2,6-dichloroindophenol (DCIP)–oxidoreductase
(complex II) and succinate:cytochrome c oxidoreductase (complexes II–III) were
determined in homogenates from cerebral cortex according to Fischer et al. (1985).
The activity of NADH:cytochrome c oxidoreductase (complexes I–III) was assayed in
cerebral cortex homogenates according to the method described by Schapira et al.
(1990) and that of cytochrome c oxidase (complex IV) according to Rustin et al.
(1994). The methods described to measure these activities were slightly modiﬁed,
as described in details in a previous report (da Silva et al., 2002). Gly (0.1–5.0 mM)
was added to the reaction medium at the beginning of the assays, while no
metabolite was added to controls. The activities of the respiratory chain complexes
were calculated as nmol min1 mg protein1 or mmol min1 mg protein1.
2.7. Spectrophotometric analyses of the activities of citric acid cycle enzymes
The activities of the enzymes of the citric acid cycle (CAC)were determined using
enriched mitochondrial fractions from whole brain. Gly was supplemented to the
medium and submitted to a pre-incubation at 37 8C for 30 min.
Citrate synthase activity was measured according to Srere (1969), by
determining DTNB reduction at l = 412 nm. The activity of the enzyme aconitase
was measured according to Morrison (1954), following the reduction of NADP+ at
wavelengths of excitation and emission of 340 and 466 nm, respectively. Isocitrate
dehydrogenase activity was accessed by the method of Plaut (1969), by following
Fig. 1. Effect of glycine (Gly) on 14CO2 production from [U-
14C] glucose, [1-14C]
acetate and [1,5-14C] citrate in rat cerebral cortex (A). In some experiments 14CO2
production was measured in the presence of [1-14C] acetate and coenzyme A (CoA)
at 1 mM (B). Values are mean  standard deviation for ﬁve to six independent
experiments (animals) per group and expressed as pmol 14CO2 h
1 g tissue1.
*p < 0.05, **p < 0.01 and ***p < 0.001, compared to controls (ANOVA followed by
Duncan multiple range test).
Fig. 2. Effect of glycine on citrate synthase activity in enriched mitochondrial
fractions from rat whole brain. Values are mean  standard deviation of six
independent experiments (animals) performed in triplicate and are expressed as
nmol DTNB reduction min1 mg protein1. *p < 0.05, compared to control (ANOVA
followed by Duncan multiple range test).
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respectively. The activity ofa-ketoglutarate dehydrogenase complexwas evaluated
according to Lai and Cooper (1986) and Tretter and Adam-Vizi (2004), with slight
modiﬁcations (Viegas et al., 2009). The reduction of NAD+ was recorded in a Hitachi
F-4500 spectroﬂuorometer at wavelengths of excitation and emission of 340 and
466 nm, respectively. The activity of succinate dehydrogenase was determined as
described by Fischer et al. (1985). Fumarase activity was measured according to
O’Hare and Doonan (1985), measuring the increase of absorbance at l = 250 nm.
Malate dehydrogenase activity was measured according to Kitto (1969) by
following the reduction of NADH at wavelengths of excitation and emission
of 340 and 466 nm, respectively. The activities of the citric acid cycle enzymes
were calculated as nmol min1 mg protein1, mmol min1 mg protein1 or
mmol min1 mg protein1.
2.8. Spectrophotometric analysis of creatine kinase (CK) activity
CK activity was measured in total homogenates as well as in the cytosolic and
mitochondrial preparations according to Hughes (1962) with slight modiﬁcations
(Schuck et al., 2002). Brieﬂy, the reactionmixture consisted of 50 mMTris buffer, pH
7.5, containing 7.0 mM phosphocreatine, 7.5 mMMgSO4, and 0.5–1.0 mg protein in
a ﬁnal volume of 0.1 mL. Gly (0.1–5.0 mM) was supplemented to the medium and
submitted to a pre-incubation at 37 8C for 30 min. The reaction was then started by
the addition of 4.0 mM ADP and stopped after 10 min by the addition of 0.02 mL of
50 mM p-hydroxy-mercuribenzoic acid. The creatine formed was estimated
according to the colorimetric method of Hughes (1962). The colour was developed
by the addition of 0.1 mL 20% a-naphthol and 0.1 mL 20% diacetyl in a ﬁnal volume
of 1.0 mL and read after 20 min at l = 540 nm. Results were calculated as mmol of
creatine min1 mg protein1.
2.9. Spectrophotometric analysis of Na+, K+-ATPase activity
The reaction mixture for the Na+, K+-ATPase assay contained 5 mM MgCl2,
80 mM NaCl, 20 mM KCl, 40 mM Tris–HCl buffer, pH 7.4, and puriﬁed synaptic
membranes (approximately 3mg of protein) in a ﬁnal volume of 200mL. The
enzymatic assay occurred at 37 8C during 5 min and started by the addition of ATP
(disodium salt, vanadium free) to a ﬁnal concentration of 3 mM. The reaction was
stopped by the addition of 200 mL of 10% trichloroacetic acid. Mg2+-ATPase
ouabain-insensitive was assayed under the same conditions with the addition of
1 mMouabain. Na+,K+-ATPase activitywas calculated by the difference between the
two assays (Tsakiris and Deliconstantinos, 1984). Released inorganic phosphate (Pi)
was measured by the method of Chan et al. (1986). Enzyme-speciﬁc activities were
calculated as nmol Pi released1 min1 mg protein.
2.10. Protein determination
Protein was measured by the methods of Lowry et al. (1951) using bovine serum
albumin as standard.
2.11. Statistical analysis
Unless otherwise stated, results are presented as mean  standard deviation.
Assays were performed in duplicate or triplicate and the mean or median was used
for statistical analysis. Data was analyzed using one-way analysis of variance
(ANOVA) followed by the post hoc Duncan multiple range test when F was
signiﬁcant. Linear regression analysis was also employed to detect dose-dependent
effects. The Student’s t-test for paired samples was used for comparison of two
means. Only signiﬁcant F and t values are shown in the text. Differences between
groups were rated signiﬁcant at p < 0.05. All analyses were carried out in an IBM-
compatible PC computer using the Statistical Package for the Social Sciences (SPSS)
software.
3. Results
3.1. Glycine inhibits CO2 production from acetate in rat cerebral cortex
It was ﬁrst investigated the effect of Gly on CO2 production from
labeled substrates in rat cortical homogenates. Fig. 1A shows that
CO2 production from [1-
14C] acetate was signiﬁcantly inhibited by
Gly at low concentrations [F(4,20) = 8.133; p < 0.001] in a dose-
dependent manner [b = 0.508, p < 0.01]. In contrast, CO2
production from [U-14C] glucose or [1,5-14C] citrate was not
altered even at high Gly concentrations (up to 5 mM). Gly-induced
inhibition did not change when 1.0 mM CoA was added to the
medium [F(3,20) = 8.068; p < 0.01]. We therefore ruled out that
the inhibitory effect of Gly could be due to a relative shortage of
coenzyme A (CoA) availability due to a competition between Glyand acetate for the CoA leading to reduced acetyl-CoA formation
and consequently to low CO2 production (Fig. 1B). On the other
hand, alanine (up to 5 mM) did not modify CO2 production from
labeled glucose or acetate (data not shown). These results strongly
suggest that the citric cycle acid (CAC) activity is compromised by
Gly.
3.2. Glycine inhibits citrate synthase activity in mitochondrial
enriched fractions from whole brain
The next set of experiments was performed in order to
evaluate the effect of Gly on CAC enzyme activities in an attempt
to elucidate whether the inhibitory effects of this amino acid on
CO2 production from [1-
14C] acetate could be due to an
inhibition of one or more steps of the CAC. We found that Gly
signiﬁcantly inhibited citrate synthase activity in mitochondrial
enriched fractions from whole brain [F(4,25) = 3.674, p < 0.05]
(Fig. 2). In contrast, this compound did not alter aconitase,
isocitrate dehydrogenase, a-ketoglutarate dehydrogenase,
Table 1
Effect of glycine (Gly) on the activities of the citric acid cycle enzymes in enriched mitochondrial fractions from rat cerebrum.
Aconitase Isocitrate dehydrogenase a-Ketoglutarate dehydrogenase Succinate dehydrogenase Fumarase Malate dehydrogenase
Control 13718.1 24447.3 1.36 0.42 45.27.91 2458.84 10124.9
5mM Gly 15534.0 24048.6 1.46 0.24 46.910.4 2456.87 98.022.5
Values are mean standard deviation for four to ﬁve independent (animals) experiments per group. The activities of isocitrate dehydrogenase and malate dehydrogenase
are expressed as nmolNADHmin1mgprotein1, whereas aconitase, a-ketoglutarate dehydrogenase, succinate dehydrogenase and fumarase are expressed as
mMNADPHmin1mgprotein1, mMNADHmin1mgprotein1, as nmolDCIPmin1mgprotein1 and nmol fumaratemin1mgprotein1, respectively. No signiﬁcant differences
were detected (one-way ANOVA).
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activities (Table 1). These data are in agreement with the fact
that CO2 formation from citrate was not altered by Gly.
Therefore, inhibition of citrate synthase activity is probably
responsible for the inhibitory action of Gly on the CAC (lower
CO2 production).
3.3. Glycine inhibits complexes I–III, II and II–III activity of the
respiratory chain in rat cerebral cortex
The next step of experiments was designed to investigate the
effect of Gly on the various respiratory chain complex enzyme
activities in an attempt to elucidate whether the electron transfer
ﬂow could be altered by Gly. We found that Gly signiﬁcantly
inhibited complexes I–III [F(4,15) = 3.273, p < 0.05], II
[F(4,25) = 4.080, p < 0.01] and II–III activities [F(4,20) = 3.111,
p < 0.05] (Fig. 3), with no signiﬁcant alteration of complex IV
activity.
3.4. Glycine inhibits creatine kinase activity from rat cerebral cortex
We then examined the effect Gly on total creatine kinase (tCK)
activity in homogenates from rat cerebral cortex. Gly signiﬁcantlyFig. 3. Effect of glycine on the activities of respiratory chain complexes in rat cerebral cor
experiments (animals) per group. The activity of complexes I–III (A) is expressed as nmol cyt
IV (D) are expressed, respectively, as nmol DCIP reduced min1 mg protein1,
oxidized min1 mg protein1. *p < 0.05 compared to control (ANOVA followed by Duncaninhibited tCK activity [F(4,25) = 16.875, p < 0.05] in a dose-
dependent manner (b = 0.780, p < 0.01) (Fig. 4A). Fig. 4C shows
that the activity on mitochondrial CK (mCK) was signiﬁcantly
inhibited by Gly [F(4,25) = 2.982, p < 0.05; b = 0.422, p < 0.05],
with no alteration of the cytosolic CK isoform (cCK) (Fig. 4B) in rat
cerebral cortex. In contrast, tCK activity was not altered by alanine
(up to 5 mM) (data not shown).
3.5. Glycine inhibits Na+,K+-ATPase activity from synaptic plasma
membranes of rat cerebral cortex
Finally, we tested the inﬂuence Gly on Na+,K+-ATPase activity in
synaptic plasma membranes prepared from whole brain homo-
genates. Fig. 5 shows puriﬁed synaptic membrane preparations
exposed to Gly resulted in a signiﬁcant inhibition of Na+,K+-ATPase
activity [F(4,25) = 3.868, p < 0.05]. On the other hand, alanine (up
to 5 mM) did not change Na+,K+-ATPase activity (data not shown).
4. Discussion
Patients affected by nonketotic hyperglycinemia (NKH) com-
monly present severe neurological dysfunction with acute
encephalopathy and intractable convulsions. The biochemicaltical homogenates. Values are mean  standard deviation for four to six independent
ochrome c reduced min1 mg protein1. The activities of complexes II (B), II–III (C) and
nmol cytochrome c reduced min1 mg protein1 and nmol cytochrome c
multiple range test).
Fig. 4. Effect of glycine on total (A), cytosolic (B) and mitochondrial (C) creatine
kinase (CK) activities in cerebral cortex preparations from rats. Values are
mean  standard deviation of six independent experiments (animals) performed in
triplicate and are expressed as mmol creatine min1 mg protein1. *p < 0.05,
**p < 0.01 and ***p < 0.001, compared to control (ANOVA followed by Duncan
multiple range test).
Fig. 5. Effect of glycine on Na+,K+-ATPase activity in puriﬁed synaptic plasma
membranes prepared from rat whole brain homogenates. Values are
mean  standard deviation of six independent experiments (animals) performed in
triplicate and are expressed as nmol Pi min1 mg protein1. *p < 0.05, compared to
control (ANOVA followed by Duncan multiple range test).
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mainly in the brain and CSF, which may achieve 5 mM, but also in
the blood and urine especially during episodes of acute decom-
pensation.
Although severe cerebral damage characterized by progressive
cortical brain atrophy with leukodystrophy of the white matter is
usually seen in the affected patients, the underlying mechanisms
involved in the neuropathology of this disease are poorly known. In
this context, it has been postulated that excitotoxicity may be
involved in this disorder since Gly stimulates the NMDA glutamate
receptors (Patel et al., 1990; McNamara and Dingledine, 1990;
Hara et al., 1993; Kure et al., 1997; Kono et al., 2007; Katsuki et al.,
2007), acting as a co-agonist of these receptors. However, more
studies are necessary to unravel the pathomechanisms of brain
injury in NKH. Hyperglycinemia is also characteristic of methyl-
malonic acidemia and propionic acidemia (previously known as
ketotic hyperglycinemia), two inherited metabolic disorderscharacterized by severe neurological dysfunction and brain
cortical atrophy. Recently, mitochondrial dysfunction has been
reported in patients with methylmalonic acidemia (Schwab et al.,
2006).
In the present study, we investigated the in vitro effects of Gly
on various parameters of energy metabolism in cerebral cortex of
young rats in the hope to verify whether Gly could compromise
brain energy homeostasis. We initially veriﬁed that Gly did not
affect 14CO2 formation from glucose in brain cortex, suggesting
that the glycolytic pathway was not affected by Gly. In contrast,
acetate oxidation was markedly reduced by the presence of Gly in
the incubationmedium. Assayswith coenzymeA supplementation
showed that shortage of this coenzyme could not be responsible
for the Gly-induced reduction of 14CO2 production. The data
indicate that the citric acid cycle (CAC) activity was disturbed by
Gly. This could be due to an inhibition of one or more steps of the
CAC or alternatively secondary to a blockage of the transport of
electrons trough the respiratory chain. We also observed that
14CO2 production from citrate was not altered by the presence of
Gly, indicating that CAC activity from citrate downwards was not
affected by this amino acid and that the probable site of blockage
was between acetate and citrate synthesis.
The next step of the investigation was therefore to evaluate
whether Gly could alter the enzyme activities of the CAC. We
veriﬁed that citrate synthase was signiﬁcantly inhibited by Gly,
whereas aconitase, isocitrate dehydrogenase, a-ketoglutarate
dehydrogenase, succinate dehydrogense, fumarase and malate
dehydrogenase activities were not changed by this compound.
These results probably explain the reduction of CO2 generation and
indicate that Gly blocks the CAC by inhibiting the ﬁrst step of this
cycle.
We also tested the effects of Gly on the respiratory chain
function by measuring the activities of complexes I–IV. We found
that Gly signiﬁcantly inhibited the activities of the respiratory
chain complexes I–III, II and II–III, without affecting complex IV
activity, implying that it reduces the electron transport chain ﬂow,
involved in almost all energy (ATP) produced in the cell. Taken
together these data, it can be presumed that energy production is
compromised by Gly in cerebral cortex of young rats.
We also demonstrated here that mCK activity, which is
essential for intracellular energy buffering and transference, was
inhibited by Gly. These observations are important since this
enzyme activity, mainly responsible for ATP buffering and transfer
within the cell, is crucial for normal brain cell functioning and has
been recognized as an importantmetabolic regulator during health
and disease (Wyss et al., 1992; Hamman et al., 1995; Gross et al.,
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stressed thatmCK activity decreases after brain exposure to agents
promoting generation of free radicals probably by oxidation of
essential cysteine residues of the enzyme (Burmistrov et al., 1992;
Wolosker et al., 1999; Arstall et al., 1998; Konorev et al., 1998;
Stachowiak et al., 1998; Wallimann et al., 1998) and that we have
recently demonstrated that Gly elicits lipid and protein oxidation
and decreases GSH concentrations in rat brain (Leipnitz et al.,
2008).
Finally, Na+,K+-ATPase activity was also signiﬁcantly inhibited
when Gly was exposed to puriﬁed plasma synaptic membranes
from rat brain. Na+,K+-ATPase is a crucial enzyme responsible for
the generation of the membrane potential through the active
transport of sodium and potassium ions in the CNS, necessary to
maintain neuronal excitability and cellular volume control. It is
present at high concentrations in the brain cellular membrane,
consuming about 40–50% of the ATP generated in this tissue, and is
highly responsive to changes in membrane ﬂuidity (Wheeler et al.,
1975; Erecinska and Silver, 1994; Erecinska et al., 2004).
Maintenance of Na+,K+-ATPase activity is critical for normal brain
function, and reduction of its activity is related to selective
neuronal damage in rat and human brain (Lees et al., 1990; Lees,
1993; Cousin et al., 1995; Lees and Leong, 1995). As regards to the
mechanism of Gly-induced decrease of Na+,K+-ATPase activity,
increasing evidence is emerging demonstrating that Na+,K+-ATPase
is highly vulnerable to free radical attack (Lees, 1993; Kurella et al.,
1997; Yousef et al., 2002). Therefore, we cannot rule out that Gly
elicited free radicals, reducing Na+,K+-ATPase and mCK activities.
Relatively to the possible consequences of the inhibition of
Na+,K+-ATPase activity provoked by Gly to neural cellular function,
there is increasing evidence suggesting that alterations in Na+,K+-
ATPase activity may be a link between common neurotoxic
mechanisms in neurons (Sweadner, 1979; Lees, 1991, 1993; Satoh
and Nakazato, 1992). Furthermore, inhibition of Na+,K+-ATPase has
also been associated with excitotoxicity and epilepsy (Grisar,
1984; Ben-Ari, 1985; Choi and Rothman, 1990; Cousin et al., 1995;
Lees and Leong, 1995).
On the other hand, since alanine was not able to affect CO2
production from labeled glucose or acetate, as well as creatine
kinase and Na+,K+-ATPase activities, it may be concluded that the
Gly effects on brain bioenergetics were speciﬁc for this amino acid.
It is difﬁcult to determine the pathophysiological relevance of
our in vitro data. However, it should be noted that the effects
observed in our present investigation occurred with Gly tissue
levels similar or even lower than those found in NKH and ketotic
hyperglycinemia (Hamosh and Johnston, 2001). It is also feasible
that even higher brain Gly concentrations may take place in stress
situations, such as occurs in various inborn disorders during
episodes of metabolic decompensation characterized by intense
catabolism and proteolysis in which the levels of the accumulating
metabolites within neural cells predominate over those found in
plasma and CSF (Hoffmann et al., 1993). Furthermore, although we
cannot assume that the degree of inhibition found in our
experiments (up to 35%) is deleterious to the neural cells, this
may be the case since they affect crucial steps involved in ATP
formation (citric acid cycle activity and oxidative phosphoryla-
tion), transfer (creatine kinase activity) and utilization (Na+,K+-
ATPase activity) that may lead to apoptosis (Lees and Leong, 1995;
Gibson et al., 2010).
On the other hand, alterations in the expression and function of
Gly transporters in different neural cell types at both synaptic and
nonsynaptic regionswere recently shown to be involved in various
physiological and pathological processes, including ischemia and
neurodegeneration (Papp et al., 2007; Raiteri et al., 2007).
Additionally, Gly transporters are also involved in the interactions
between the various neurotransmitter systems (Kallo´ et al., 2007;Sershen et al., 2008; Brouns et al., 2010), so that it cannot be ruled
out that high brain Gly concentrations may affect these mechan-
isms and play an important role in the pathophysiology of NKH.
In conclusion, this is the ﬁrst report showing that Gly provokes
bioenergetics dysfunction in the brain. In case the present in vitro
data are conﬁrmed in vivo in animal experiments, it is tempting to
speculate that impairment of energy production, transfer and
utilizationmay contribute synergistically with other susceptibility
factors, such as oxidative stress (Leipnitz et al., 2008) and
excitotoxicity (Patel et al., 1990; Katsuki et al., 2007; Kono
et al., 2007), to the neurological damage found in patients affected
by NKH and ketotic hyperglycinemia. In this scenario, the prompt
and aggressive treatment of infections and management of fever
during acute metabolic decompensation reducing the risk of
increased catabolism with elevation of brain Gly concentrations
seems justiﬁed and may prevent irreversible brain injury with
consequent cognitive impairment and seizures in these patients.
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